DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



[Controlled release metoprolol succinate in MERIT-HF. Analysis of patients subgroups]

Author(s): Sidorenko BA, Bugrimova MA, Iosava IK, Pataraia SA, Preobrazhenskii DV

Affiliation(s): Presidential Medical Center of Russia, Moscow, Russia.

Publication date & source: 2008, Kardiologiia., 48(3):85-8.

Publication type: English Abstract

Results of the investigation of metoprolol CR/XL which was conducted in large randomized controlled study MERIT-HF in patients with chronic heart failure (CHF) are presented. In the whole trial this beta1-selective blocker lowered mortality of patients with CHF. Analysis of results in subgroups shows that metoprolol CR/XL was equally effective in middle aged and old patients, in men and women.

Page last updated: 2008-06-22

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017